Expanding newborn screening (NBS) to include detecting genes linked to an increased risk of neurodevelopmental disorders (NDD) will do more harm than good, claimed a recent Paediatrics article.
According to a recent Paediatrics article, expanding newborn screening (NBS) to include identifying genes associated with an elevated risk of neurodevelopmental disorders (NDD) will cause more harm than good. While some experts believe that identifying NDDs in the newborn period would be a
A recent study discovered that population-based genomic screening can help in the early diagnosis of medullary thyroid cancer (MTC) in patients with RET gene variations.